Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes
[39] [49] [265] In humans, phenethylamine is produced directly from L-phenylalanine by the aromatic amino acid decarboxylase (AADC) enzyme, which converts L-DOPA into dopamine as well
Similarly, applying retatrutide concentrations to semaglutide would create volumes so small they are nearly impossible to measure
Trachootham et al., 2008
Gynecol Endocrinol 40(1):2328613
The clinics signature 90-day program is results-driven, safe, and personalized
US$ 25.05
US$ 24.77
US$ 28.48
US$ 26.97
US$ 26.01
US$ 27.98
